These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2157115)

  • 1. Polyadenylic acid polymerase activity in chronic myelogenous leukemia.
    Sasaki R; Minowada J; Bollum FJ; Miura Y
    Leuk Res; 1990; 14(3):273-8. PubMed ID: 2157115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinoic acid and 12-0-tetradecanoylphorbol-13-acetate (TPA) inducing bipotent differentiation of cultured primary bone marrow cells from leukemia patients].
    Chen ZX; Wu WL
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):26-9. PubMed ID: 1889336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase: obviously activated in the accelerated phase of chronic myeloid leukemia.
    Li G; Song YH; Qian LS; Ma XT; Wu KF
    Haematologica; 2000 Nov; 85(11):1222-4. PubMed ID: 11064478
    [No Abstract]   [Full Text] [Related]  

  • 4. Polyadenylic acid metabolizing enzyme levels during induction of differentiation in a human leukemia T-cell line with phorbol ester.
    Perez S; Trangas T; Kokkinopoulos D; Tsiapalis CM; Papamichail M
    J Natl Cancer Inst; 1987 Mar; 78(3):407-11. PubMed ID: 3029496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polyadenylate polymerase in blood serum from hemoblastosis patients].
    Egorova VA; Blinov MN; Abdulkadyrov KM
    Vopr Med Khim; 1994; 40(1):27-9. PubMed ID: 8122405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in serum RNase activities in chronic phase and acute crisis of chronic myelocytic leukemia].
    Maruoka K; Yamanaka M; Misago M; Nakata K; Tsukada J; Nagata K; Sato T; Mori N; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jul; 30(7):988-93. PubMed ID: 2810801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5'-monophosphate-N-acetylneuraminic acid:Gal beta 1-3GalNAc alpha (2-3)-sialyltransferase.
    Kanani A; Sutherland DR; Fibach E; Matta KL; Hindenburg A; Brockhausen I; Kuhns W; Taub RN; van den Eijnden DH; Baker MA
    Cancer Res; 1990 Aug; 50(16):5003-7. PubMed ID: 2379165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
    J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
    Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
    Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
    Chen ZX; Wang W; Wu WL
    Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute bilineage leukemia after chronic myelogenous leukemia.
    Williams SR; Wellhausen SR; Barker RL; Janckila AJ
    J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis.
    Kimura A; Nakata Y; Hyodo H; Kuramoto A; Satow Y
    Br J Haematol; 1994 Feb; 86(2):303-7. PubMed ID: 8199019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis.
    Yoshimura M; Nishikawa A; Ihara Y; Nishiura T; Nakao H; Kanayama Y; Matuzawa Y; Taniguchi N
    Int J Cancer; 1995 Feb; 60(4):443-9. PubMed ID: 7829256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.